News
17hon MSN
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Pharmaceutical Technology on MSN23h
Novo Nordisk’s CEO to step down as weight loss market share plummetsNovo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...
Zacks Investment Research on MSN20h
Novo Nordisk Shares Dip 3% on Sudden CEO Transition AnnouncementNovo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership ...
As Lars Fruergaard Jørgensen steps, Novo Nordisk seeks new leadership while production hurdles impact the competitive ...
A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...
An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback